VANGUARD GROUP INC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$2,347,674
+16.6%
2,898,363
+0.8%
0.00%
Q1 2023$2,013,734
-0.2%
2,876,763
+0.6%
0.00%
Q4 2022$2,018,488
-53.0%
2,859,049
+1.2%
0.00%
Q3 2022$4,295,000
+87.7%
2,825,643
+22.6%
0.00%
Q2 2022$2,288,000
+20.4%
2,304,987
+74.6%
0.00%
Q1 2022$1,901,000
-79.8%
1,320,238
-26.6%
0.00%
Q4 2021$9,390,000
-7.1%
1,798,772
+3.8%
0.00%
Q3 2021$10,104,000
-26.1%
1,732,986
+2.1%
0.00%
Q2 2021$13,675,000
+2.1%
1,696,535
+5.4%
0.00%
Q1 2021$13,390,000
+7.1%
1,609,491
-2.4%
0.00%
Q4 2020$12,505,000
-28.4%
1,649,825
+0.7%
0.00%
-100.0%
Q3 2020$17,457,000
-23.6%
1,637,719
+8.7%
0.00%0.0%
Q2 2020$22,842,000
+92.0%
1,506,736
+5.5%
0.00%0.0%
Q1 2020$11,897,000
-50.5%
1,428,172
+0.4%
0.00%0.0%
Q4 2019$24,028,000
-8.3%
1,421,811
+0.7%
0.00%0.0%
Q3 2019$26,215,000
-17.7%
1,411,706
+1.4%
0.00%0.0%
Q2 2019$31,861,000
+9.3%
1,392,496
+0.4%
0.00%0.0%
Q1 2019$29,163,000
+85.3%
1,387,455
+1.4%
0.00%0.0%
Q4 2018$15,737,000
-46.9%
1,368,390
+6.0%
0.00%0.0%
Q3 2018$29,638,000
+3.8%
1,291,417
+0.8%
0.00%0.0%
Q2 2018$28,562,000
-8.0%
1,280,816
-5.8%
0.00%0.0%
Q1 2018$31,059,000
-11.1%
1,359,243
+2.0%
0.00%
-50.0%
Q4 2017$34,927,000
+20.7%
1,333,109
+3.4%
0.00%
+100.0%
Q3 2017$28,949,000
-14.4%
1,289,479
+4.2%
0.00%
-50.0%
Q2 2017$33,837,000
+20.6%
1,237,174
+6.7%
0.00%
+100.0%
Q1 2017$28,058,000
+28.6%
1,159,421
+10.3%
0.00%0.0%
Q4 2016$21,818,000
-23.7%
1,051,444
+0.2%
0.00%
-50.0%
Q3 2016$28,603,000
+81.7%
1,049,286
-4.1%
0.00%
+100.0%
Q2 2016$15,746,000
+0.9%
1,094,271
+0.7%
0.00%0.0%
Q1 2016$15,611,000
-27.9%
1,086,346
+7.9%
0.00%0.0%
Q4 2015$21,643,000
-93.0%
1,007,160
-88.5%
0.00%
-91.7%
Q3 2015$310,587,000
+1330.9%
8,750,824
+940.5%
0.01%
+1100.0%
Q2 2015$21,705,000
+16.8%
840,993
+1.8%
0.00%0.0%
Q1 2015$18,581,000
+21.8%
825,832
+3.9%
0.00%0.0%
Q4 2014$15,256,000
-6.3%
795,019
+4.9%
0.00%0.0%
Q3 2014$16,275,000
+5.3%
757,693
+27.5%
0.00%0.0%
Q2 2014$15,452,000
+23.9%
594,272
+3.9%
0.00%0.0%
Q1 2014$12,475,000
+119.7%
572,020
+22.9%
0.00%
Q4 2013$5,678,000
+8.1%
465,369
+18.8%
0.00%
-100.0%
Q3 2013$5,251,000
+117.3%
391,608
+31.5%
0.00%
Q2 2013$2,417,000297,7520.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders